Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for inducing and disintegrating human amniotic mesenchymal cell to form osteocyte or cartilage cell

A chondrocyte and cell-induced technology, applied in animal cells, vertebrate cells, bone/connective tissue cells, etc., can solve the problems of tumorigenicity, difficult clinical application, and uncertain efficacy.

Active Publication Date: 2012-05-02
北京科润维德生物技术有限责任公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently commonly used methods include: drugs (inhibiting osteoclastosis, promoting osteogenesis), drilling decompression, autologous or allogeneic fibula transplantation, compression bone grafting, circumflex iliac artery grafting, acetabular rotational osteotomy, stem cell transplantation surgery, etc., but no method can effectively prevent the process of femoral head collapse
In theory, stem cell transplantation is an ideal method to delay the collapse of the femoral head, but due to the limited amount of autologous bone marrow stromal stem cells, the curative effect is uncertain
Although in vitro culture and replantation can obtain a large number of stem cells, they are tumorigenic and difficult to obtain clinical application.
In addition to BMSCs, some scholars have induced embryonic stem cells (ESCs) to differentiate into bone and chondrocytes, but teratomas and immune rejection are likely to occur after allogeneic transplantation. In addition, the application of embryos also involves laws and ethics. problems, which limit their wide application in clinical

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inducing and disintegrating human amniotic mesenchymal cell to form osteocyte or cartilage cell
  • Method for inducing and disintegrating human amniotic mesenchymal cell to form osteocyte or cartilage cell

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031] A method of inducing human amniotic mesenchymal cells to differentiate into bone or chondrocytes of the present invention, comprising:

[0032] (1) Under sterile conditions, the human amniotic membrane tissue bluntly isolated from the umbilical cord surface of a placenta of a normal full-term cesarean section fetus is soaked in normal saline;

[0033] (2) Pour off the physiological saline in step (1), and wash the above-mentioned human amniotic membrane tissue with the physiological saline solution containing 100IU / ml penicillin and 100ug / ml streptomycin mixed solution with a temperature of 4°C until the human amniotic tissue is free of any After impurities and blood stains, wash the above-mentioned human amnion tissue 3-5 times with D-hank's containing 100IU / ml penicillin and 100ug / ml streptomycin in a sterile room at a temperature of 20-25°C, and then place it in a sterile room containing 100IU / ml Soak in ml penicillin and 100ug / ml streptomycin D-hank's solution for 2...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for inducing and disintegrating human amniotic mesenchymal cell to form osteocyte or cartilage cell. The method comprises the following steps: separating human amniotic tissue from placenta; cleaning the human amniotic tissue; digesting the cleaned human amniotic tissue; separating the human amniotic tissue into single human amniotic mesenchymal cell; performing amplification of the human amniotic mesenchymal cell to reach the desired number, adding human amniotic mesenchymal cell suspending solution in high sugar DMEM culture medium with 5% of FBS, 10ng / ml of TGF-beta1, 10ng / ml of IGF, 0.1mu M of decamethasone and 50ng / ml of ascorbic acid to perform induction culture for 21 days while changing the culture medium once per 24h and obtaining the osteocyte or cartilage cell. By using the method of the invention, the osteocyte or cartilage cell can be obtained to repair the bone tissue or cartilage tissue in human body so as to cure the bone defect.

Description

technical field [0001] Since human amnion mesenchymal cells (human Amnion mesenchymal cells, hAMCs) have stem cell biological characteristics such as proliferation activity and multi-differentiation potential, the present invention relates to a method for inducing human amnion mesenchymal cells to differentiate into bone or chondrocytes . Background technique [0002] Avascular necrosis of the femoral head (AVN avascular necrosis of the femoral head), also known as aseptic necrosis of the femoral head (ANFH aseptic necrosis of femoral head) or ONFH osteonecrosis of the femoral head, is a refractory orthopedic disease. Diseases, the use of corticosteroids (corticosteroid, hereinafter referred to as hormones) and excessive drinking in my country are one of the main causes of non-traumatic ONFH. Necrosis of the femoral head is a progressive and disabling disease, most of which end in joint collapse and require artificial joint replacement. Currently commonly used methods inclu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/077
Inventor 张向利肖静吴亦芳张红霞郭丽丽王月郭敏孟昭霞刘艳军曹克富王瑞兰范育红李荣旗
Owner 北京科润维德生物技术有限责任公司